Explore our comprehensive coverage of gene editing, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.
An NIH-funded research team has engineered a significantly smaller and more stable CRISPR enzyme, Al3Cas12f RKK, enabling precise in-vivo gene editing...
Read Full Story →
Medical ResearchVerve Therapeutics' in vivo CRISPR base editing program, VERVE-102, utilizes lipid nanoparticles to ...
HealthVerve Therapeutics has announced groundbreaking Phase 2 trial results showing that a single CRISPR b...
